Nano Global and Arm to develop AI chip for health data capture

23 November 2017 (Last Updated November 23rd, 2017 10:33)

Molecular data firm Nano Global is set to use semiconductor IP company Arm’s intellectual property (IP) for the development of an artificial intelligence (AI) chip to capture health-related molecular data.

Molecular data firm Nano Global is set to use semiconductor IP company Arm’s intellectual property (IP) for the development of an artificial intelligence (AI) chip to capture health-related molecular data.

The system-on-chip (SoC) technology is expected to aid in addressing global health challenges such as superbugs, infectious diseases and cancer.

It will be designed to yield highly secure data that could be used for the identification and analysis of health threats due to pathogens and other living organisms.

Nano Global chairman and CEO Steve Papermaster said: “In partnership with Arm, we’re tackling the vast frontier of molecular data to unlock the unlimited potential of this universe.

“The data our technology can acquire and process will enable us to create a safer and healthier world.”

“The data our technology can acquire and process will enable us to create a safer and healthier world.”

In addition to the scientific technology platform and AI, the SoC will utilise nanotechnology, optics, blockchain authentication and edge computing for accessing and analysing data in real time.

Arm IPG executive vice-president and president Rene Haas said: “We believe the technology Nano Global is delivering will be an important step forward in the collective pursuit of care that improves lives through the application of technology.

“By collaborating with Nano Global, Arm is taking an active role in developing and deploying the technologies that will move us one step closer to solving complex health challenges.”

The first delivery of the chip is scheduled to take place in 2020.

Nano Global is planning to further partner with institutions such as Baylor College of Medicine and National University of Singapore to advance data collection, analysis and product development for research in clinical, laboratory and population health environments.